Company / PP&E per Share
ARS Pharmaceuticals, Inc. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.03
FY2025
5-year range
$0.00 / $0.03
FY2021-FY2025
Trend
+127.6%
vs FY2024
Sector context
#139 of 191
Health Care
What the data says
At $0.03, ARS Pharmaceuticals, Inc.'s pp&e per share ranks #139 of 191 in the Health Care sector. PP&E per Share has fluctuated over the past 6 years, ranging from $0.00 in FY2021 to $0.56 in FY2020.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -46.2%.
Improved from $0.01 to $0.03 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +32.4%
- 5-Year CAGR
- -46.2%
- 10-Year CAGR
- -
Sector benchmark
#139 of 191 in Health CareTop 73% of 191This company $0.03 Sector average $22.34
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 127.6% year-over-year.
- Ranks #139 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
- Lowest pp&e per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | +127.6% |
| FY2024 | $0.01 | +81.0% |
| FY2023 | $0.01 | -43.6% |
| FY2022 | $0.01 | +334.4% |
| FY2021 | $0.00 | -99.6% |
| FY2020 | $0.56 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026